Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 471

1.

Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy.

Herraets IJT, Bakers JNE, van Eijk RPA, Goedee HS, van der Pol WL, van den Berg LH.

J Neurol. 2019 Jul 19. doi: 10.1007/s00415-019-09475-x. [Epub ahead of print]

PMID:
31325017
2.

Nerve ultrasound can identify treatment-responsive chronic neuropathies without electrodiagnostic features of demyelination.

Goedee HS, Herraets I, Visser LH, Franssen H, van Asseldonk J, van der Pol WL, van den Berg LH.

Muscle Nerve. 2019 Jul 11. doi: 10.1002/mus.26629. [Epub ahead of print]

PMID:
31294858
3.

Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.

van Eijk RPA, Nikolakopoulos S, Roes KCB, Middelkoop BM, Ferguson TA, Shaw PJ, Leigh PN, Al-Chalabi A, Eijkemans MJC, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2019 Jul 10. pii: jnnp-2019-320998. doi: 10.1136/jnnp-2019-320998. [Epub ahead of print]

4.

Simulating perinodal changes observed in immune-mediated neuropathies - Impact on conduction in a model of myelinated motor and sensory axons.

Sleutjes BTHM, Kovalchuk MO, Durmus N, Buitenweg JR, van Putten MJAM, van den Berg LH, Franssen H.

J Neurophysiol. 2019 Jul 10. doi: 10.1152/jn.00326.2019. [Epub ahead of print]

PMID:
31291151
5.

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.

Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-10. doi: 10.1080/21678421.2019.1632899. [Epub ahead of print]

PMID:
31284774
6.

A case of ALS with posterior cortical atrophy.

Nijboer TCW, Nitert B, Westeneng HJ, Van Den Berg LH, van Es MA.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-5. doi: 10.1080/21678421.2019.1632348. [Epub ahead of print]

PMID:
31284766
7.

Amyotrophic lateral sclerosis as a multi-step process: an Australia population study.

Vucic S, Westeneng HJ, Al-Chalabi A, Van Den Berg LH, Talman P, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-6. doi: 10.1080/21678421.2018.1556697. [Epub ahead of print]

PMID:
31284763
8.

The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public.

van der Spek RAA, van Rheenen W, Pulit SL, Kenna KP, van den Berg LH, Veldink JH; Project MinE ALS Sequencing Consortium¶.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):432-440. doi: 10.1080/21678421.2019.1606244.

PMID:
31280677
9.

Implications of spirometric reference values for amyotrophic lateral sclerosis.

van Eijk RPA, Bakers JNE, van Es MA, Eijkemans MJC, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 4:1-8. doi: 10.1080/21678421.2019.1634736. [Epub ahead of print]

PMID:
31271047
10.

Neuropathy associated with IgM monoclonal gammopathy: a combined sonographic and nerve conduction study.

Goedee S, Notermans NC, Visser LH, van Asseldonk JH, Franssen H, Vrancken A, Nikolakopoulos S, van den Berg LH, van der Pol L.

Muscle Nerve. 2019 Jul 3. doi: 10.1002/mus.26626. [Epub ahead of print]

PMID:
31269243
11.

Warming nerves for excitability testing.

Kovalchuk MO, Franssen H, Scheijmans FEV, Van Schelven LJ, Van Den Berg LH, Sleutjes BTHM.

Muscle Nerve. 2019 Jun 26. doi: 10.1002/mus.26621. [Epub ahead of print]

PMID:
31241195
12.

User perspectives on a psychosocial blended support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: a qualitative study.

de Wit J, Vervoort SCJM, van Eerden E, van den Berg LH, Visser-Meily JMA, Beelen A, Schröder CD.

BMC Psychol. 2019 Jun 15;7(1):35. doi: 10.1186/s40359-019-0308-x.

13.

Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study.

van Eijk RPA, Bakers JNE, Bunte TM, de Fockert AJ, Eijkemans MJC, van den Berg LH.

J Neurol. 2019 Jun 11. doi: 10.1007/s00415-019-09427-5. [Epub ahead of print]

PMID:
31187191
14.

Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy.

Wijngaarde CA, Brink RC, de Kort FAS, Stam M, Otto LAM, Asselman FL, Bartels B, van Eijk RPA, Sombroek J, Cuppen I, Verhoef M, van den Berg LH, Wadman RI, Castelein RM, van der Pol WL.

Neurology. 2019 Jul 9;93(2):e149-e158. doi: 10.1212/WNL.0000000000007742. Epub 2019 Jun 4.

PMID:
31164393
15.

Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis.

Ngo ST, van Eijk RPA, Chachay V, van den Berg LH, McCombe PA, Henderson RD, Steyn FJ.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May 30:1-9. doi: 10.1080/21678421.2019.1621346. [Epub ahead of print]

PMID:
31144522
16.

A neuropsychological and behavioral study of PLS.

de Vries BS, Spreij LA, Rustemeijer LMM, Bakker LA, Veldink JH, van den Berg LH, Nijboer TCW, van Es MA.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):376-384. doi: 10.1080/21678421.2019.1620284. Epub 2019 May 28.

PMID:
31134825
17.

10Kin1day: A Bottom-Up Neuroimaging Initiative.

van den Heuvel MP, Scholtens LH, van der Burgh HK, Agosta F, Alloza C, Arango C, Auyeung B, Baron-Cohen S, Basaia S, Benders MJNL, Beyer F, Booij L, Braun KPJ, Filho GB, Cahn W, Cannon DM, Chaim-Avancini TM, Chan SSM, Chen EYH, Crespo-Facorro B, Crone EA, Dannlowski U, de Zwarte SMC, Dietsche B, Donohoe G, Plessis SD, Durston S, Díaz-Caneja CM, Díaz-Zuluaga AM, Emsley R, Filippi M, Frodl T, Gorges M, Graff B, Grotegerd D, Gąsecki D, Hall JM, Holleran L, Holt R, Hopman HJ, Jansen A, Janssen J, Jodzio K, Jäncke L, Kaleda VG, Kassubek J, Masouleh SK, Kircher T, Koevoets MGJC, Kostic VS, Krug A, Lawrie SM, Lebedeva IS, Lee EHM, Lett TA, Lewis SJG, Liem F, Lombardo MV, Lopez-Jaramillo C, Margulies DS, Markett S, Marques P, Martínez-Zalacaín I, McDonald C, McIntosh AM, McPhilemy G, Meinert SL, Menchón JM, Montag C, Moreira PS, Morgado P, Mothersill DO, Mérillat S, Müller HP, Nabulsi L, Najt P, Narkiewicz K, Naumczyk P, Oranje B, Ortiz-Garcia de la Foz V, Peper JS, Pineda JA, Rasser PE, Redlich R, Repple J, Reuter M, Rosa PGP, Ruigrok ANV, Sabisz A, Schall U, Seedat S, Serpa MH, Skouras S, Soriano-Mas C, Sousa N, Szurowska E, Tomyshev AS, Tordesillas-Gutierrez D, Valk SL, van den Berg LH, van Erp TGM, van Haren NEM, van Leeuwen JMC, Villringer A, Vinkers CH, Vollmar C, Waller L, Walter H, Whalley HC, Witkowska M, Witte AV, Zanetti MV, Zhang R, de Lange SC.

Front Neurol. 2019 May 9;10:425. doi: 10.3389/fneur.2019.00425. eCollection 2019.

18.

Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.

Lees JA, Ferwerda B, Kremer PHC, Wheeler NE, Serón MV, Croucher NJ, Gladstone RA, Bootsma HJ, Rots NY, Wijmega-Monsuur AJ, Sanders EAM, Trzciński K, Wyllie AL, Zwinderman AH, van den Berg LH, van Rheenen W, Veldink JH, Harboe ZB, Lundbo LF, de Groot LCPGM, van Schoor NM, van der Velde N, Ängquist LH, Sørensen TIA, Nohr EA, Mentzer AJ, Mills TC, Knight JC, du Plessis M, Nzenze S, Weiser JN, Parkhill J, Madhi S, Benfield T, von Gottberg A, van der Ende A, Brouwer MC, Barrett JC, Bentley SD, van de Beek D.

Nat Commun. 2019 May 15;10(1):2176. doi: 10.1038/s41467-019-09976-3.

19.

Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis.

Dekker AM, Diekstra FP, Pulit SL, Tazelaar GHP, van der Spek RA, van Rheenen W, van Eijk KR, Calvo A, Brunetti M, Damme PV, Robberecht W, Hardiman O, McLaughlin R, Chiò A, Sendtner M, Ludolph AC, Weishaupt JH, Pardina JSM, van den Berg LH, Veldink JH.

Sci Rep. 2019 Apr 11;9(1):5931. doi: 10.1038/s41598-019-42091-3.

20.

Two heads are better than one: benefits of joint models for ALS trials.

van Eijk RPA, Rooney J, Hardiman O, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2019 Apr 11. pii: jnnp-2019-320553. doi: 10.1136/jnnp-2019-320553. [Epub ahead of print] No abstract available.

PMID:
30975822
21.

Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk.

Visser AE, D'Ovidio F, Peters S, Vermeulen RC, Beghi E, Chiò A, Veldink JH, Logroscino G, Hardiman O, van den Berg LH; Euro-MOTOR consortium.

J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):854-860. doi: 10.1136/jnnp-2018-319779. Epub 2019 Mar 8.

PMID:
30850472
22.

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.

van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Benatar M, Berry JD, Chio A, Corcia P, Genge A, Gubitz AK, Lomen-Hoerth C, McDermott CJ, Pioro EP, Rosenfeld J, Silani V, Turner MR, Weber M, Brooks BR, Miller RG, Mitsumoto H; Airlie House ALS Clinical Trials Guidelines Group.

Neurology. 2019 Apr 2;92(14):e1610-e1623. doi: 10.1212/WNL.0000000000007242. Epub 2019 Mar 8.

23.

Serum cytokine patterns in immunoglobulin m monoclonal gammopathy-associated polyneuropathy.

Stork ACJ, Rijkers GT, Vlam L, Cats EA, de Jong BAW, Fritsch-Stork RDE, Veldink JH, van den Berg LH, Notermans NC, van der Pol WL.

Muscle Nerve. 2019 Jun;59(6):694-698. doi: 10.1002/mus.26462. Epub 2019 Mar 22.

PMID:
30847948
24.

Evidence for a multimodal effect of riluzole in patients with ALS?

de Jongh AD, van Eijk RPA, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2019 Mar 7. pii: jnnp-2018-320211. doi: 10.1136/jnnp-2018-320211. [Epub ahead of print] No abstract available.

PMID:
30846539
25.

Aerobic Exercise Therapy in Ambulatory Patients With ALS: A Randomized Controlled Trial.

van Groenestijn AC, Schröder CD, van Eijk RPA, Veldink JH, Kruitwagen-van Reenen ET, Groothuis JT, Grupstra HF, Tepper M, van Vliet RO, Visser-Meily JMA, van den Berg LH.

Neurorehabil Neural Repair. 2019 Feb;33(2):153-164. doi: 10.1177/1545968319826051.

PMID:
30744529
26.

Statins do not increase risk of polyneuropathy: A case-control study and literature review.

Warendorf JK, Vrancken AFJE, van Eijk RPA, Visser NA, van den Berg LH, Notermans NC.

Neurology. 2019 Apr 30;92(18):e2136-e2144. doi: 10.1212/WNL.0000000000007148. Epub 2019 Feb 8.

PMID:
30737334
27.

Psychological distress and coping styles of caregivers of patients with amyotrophic lateral sclerosis: a longitudinal study.

de Wit J, Bakker LA, van Groenestijn AC, Baardman JF, van den Berg LH, Visser-Meily JMA, SchrÖder CD.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):235-241. doi: 10.1080/21678421.2018.1534976. Epub 2019 Jan 18.

PMID:
30654658
28.

Associations of Electric Shock and Extremely Low-Frequency Magnetic Field Exposure With the Risk of Amyotrophic Lateral Sclerosis.

Peters S, Visser AE, D'Ovidio F, Beghi E, Chiò A, Logroscino G, Hardiman O, Kromhout H, Huss A, Veldink J, Vermeulen R, van den Berg LH; Euro-MOTOR Consortium.

Am J Epidemiol. 2019 Apr 1;188(4):796-805. doi: 10.1093/aje/kwy287.

PMID:
30649156
29.

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials.

van Eijk RPA, Westeneng HJ, Nikolakopoulos S, Verhagen IE, van Es MA, Eijkemans MJC, van den Berg LH.

Neurology. 2019 Jan 9. pii: 10.1212/WNL.0000000000006855. doi: 10.1212/WNL.0000000000006855. [Epub ahead of print]

30.

Nerve ultrasound: A reproducible diagnostic tool in peripheral neuropathy.

Telleman JA, Herraets IJT, Goedee HS, Verhamme C, Nikolakopoulos S, van Asseldonk JH, van der Pol WL, van den Berg LH, Visser LH.

Neurology. 2018 Dec 28. pii: 10.1212/WNL.0000000000006856. doi: 10.1212/WNL.0000000000006856. [Epub ahead of print]

PMID:
30593519
31.

Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort.

Tazelaar GHP, Dekker AM, van Vugt JJFA, van der Spek RA, Westeneng HJ, Kool LJBG, Kenna KP, van Rheenen W, Pulit SL, McLaughlin RL, Sproviero W, Iacoangeli A, Hübers A, Brenner D, Morrison KE, Shaw PJ, Shaw CE, Panadés MP, Mora Pardina JS, Glass JD, Hardiman O, Al-Chalabi A, van Damme P, Robberecht W, Landers JE, Ludolph AC, Weishaupt JH, van den Berg LH, Veldink JH, van Es MA; Project MinE ALS Sequencing Consortium.

Neurobiol Aging. 2019 Feb;74:234.e9-234.e15. doi: 10.1016/j.neurobiolaging.2018.09.012. Epub 2018 Sep 22.

PMID:
30342764
32.

Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen.

Bakker LA, Schröder CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, Veldink JH, Visser-Meily JMA, van den Berg LH, Nijboer TCW, van Es MA.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):19-27. doi: 10.1080/21678421.2018.1522352. Epub 2018 Oct 12. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jan 29;:1.

PMID:
30314420
33.

Microglia innately develop within cerebral organoids.

Ormel PR, Vieira de Sá R, van Bodegraven EJ, Karst H, Harschnitz O, Sneeboer MAM, Johansen LE, van Dijk RE, Scheefhals N, Berdenis van Berlekom A, Ribes Martínez E, Kling S, MacGillavry HD, van den Berg LH, Kahn RS, Hol EM, de Witte LD, Pasterkamp RJ.

Nat Commun. 2018 Oct 9;9(1):4167. doi: 10.1038/s41467-018-06684-2.

34.

A continuous repetitive task to detect fatigability in spinal muscular atrophy.

Stam M, Wadman RI, Bartels B, Leeuw M, Westeneng HJ, Wijngaarde CA, van den Berg LH, van der Pol WL.

Orphanet J Rare Dis. 2018 Sep 12;13(1):160. doi: 10.1186/s13023-018-0904-5.

35.

Nerve ultrasound and magnetic resonance imaging in the diagnosis of neuropathy.

Goedee HS, van der Pol WL, Hendrikse J, van den Berg LH.

Curr Opin Neurol. 2018 Oct;31(5):526-533. doi: 10.1097/WCO.0000000000000607. Review.

PMID:
30153189
36.

Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study.

D'Ovidio F, Rooney JPK, Visser AE, Manera U, Beghi E, Logroscino G, Vermeulen RCH, Veldink JH, van den Berg LH, Hardiman O, Chiò A; Euro-MOTOR consortium.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):11-19. doi: 10.1136/jnnp-2018-318559. Epub 2018 Aug 3.

PMID:
30076269
37.

Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes.

de Vries BS, Rustemeijer LMM, Bakker LA, Schröder CD, Veldink JH, van den Berg LH, Nijboer TCW, van Es MA.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):141-147. doi: 10.1136/jnnp-2018-318788. Epub 2018 Aug 3.

PMID:
30076267
38.

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).

Stam M, Wadman RI, Wijngaarde CA, Bartels B, Asselman FL, Otto LAM, Goedee HS, Habets LE, de Groot JF, Schoenmakers MAGC, Cuppen I, van den Berg LH, van der Pol WL.

BMJ Open. 2018 Jul 30;8(7):e019932. doi: 10.1136/bmjopen-2017-019932.

39.

The multistep hypothesis of ALS revisited: The role of genetic mutations.

Chiò A, Mazzini L, D'Alfonso S, Corrado L, Canosa A, Moglia C, Manera U, Bersano E, Brunetti M, Barberis M, Veldink JH, van den Berg LH, Pearce N, Sproviero W, McLaughlin R, Vajda A, Hardiman O, Rooney J, Mora G, Calvo A, Al-Chalabi A.

Neurology. 2018 Aug 14;91(7):e635-e642. doi: 10.1212/WNL.0000000000005996. Epub 2018 Jul 25.

40.

The life expectancy of Stephen Hawking, according to the ENCALS model.

Westeneng HJ, Al-Chalabi A, Hardiman O, Debray TP, van den Berg LH.

Lancet Neurol. 2018 Aug;17(8):662-663. doi: 10.1016/S1474-4422(18)30241-2. Epub 2018 Jul 17. No abstract available.

PMID:
30033055
41.

Social participation of adult patients with spinal muscular atrophy: Frequency, restrictions, satisfaction, and correlates.

Kruitwagen-van Reenen ET, van der Pol L, Schröder C, Wadman RI, van den Berg LH, Visser-Meily JMA, Post MWM.

Muscle Nerve. 2018 Dec;58(6):805-811. doi: 10.1002/mus.26201. Epub 2018 Nov 15.

PMID:
30028531
42.

Long-Term Air Pollution Exposure and Amyotrophic Lateral Sclerosis in Netherlands: A Population-based Case-control Study.

Seelen M, Toro Campos RA, Veldink JH, Visser AE, Hoek G, Brunekreef B, van der Kooi AJ, de Visser M, Raaphorst J, van den Berg LH, Vermeulen RCH.

Environ Health Perspect. 2017 Sep 27;125(9):097023. doi: 10.1289/EHP1115.

43.

Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study.

van Rheenen W, Diekstra FP, Harschnitz O, Westeneng HJ, van Eijk KR, Saris CGJ, Groen EJN, van Es MA, Blauw HM, van Vught PWJ, Veldink JH, van den Berg LH.

PLoS One. 2018 Jun 25;13(6):e0198874. doi: 10.1371/journal.pone.0198874. eCollection 2018.

44.

Excitability tests using high-density surface-EMG: A novel approach to studying single motor units.

Sleutjes BTHM, Drenthen J, Boskovic E, van Schelven LJ, Kovalchuk MO, Lumens PGE, van den Berg LH, Franssen H.

Clin Neurophysiol. 2018 Aug;129(8):1634-1641. doi: 10.1016/j.clinph.2018.04.754. Epub 2018 Jun 1.

PMID:
29909363
45.

A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial.

de Wit J, Beelen A, Drossaert CHC, Kolijn R, van den Berg LH, Visser-Meily JMA, Schröder CD.

BMC Psychol. 2018 May 2;6(1):20. doi: 10.1186/s40359-018-0232-5.

46.

Hypermetabolism in ALS is associated with greater functional decline and shorter survival.

Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, Heshmat S, Henders AK, Wray NR, van den Berg LH, Henderson RD, McCombe PA, Ngo ST.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1016-1023. doi: 10.1136/jnnp-2017-317887. Epub 2018 Apr 29.

47.

Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis.

Visser AE, Rooney JPK, D'Ovidio F, Westeneng HJ, Vermeulen RCH, Beghi E, Chiò A, Logroscino G, Hardiman O, Veldink JH, van den Berg LH; Euro-MOTOR consortium.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):797-803. doi: 10.1136/jnnp-2017-317724. Epub 2018 Apr 23.

PMID:
29685899
48.

Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Kovalchuk MO, Heuberger JAAC, Sleutjes BTHM, Ziagkos D, van den Berg LH, Ferguson TA, Franssen H, Groeneveld GJ.

Clin Pharmacol Ther. 2018 Dec;104(6):1136-1145. doi: 10.1002/cpt.1096. Epub 2018 Jun 19.

PMID:
29672831
49.

Understanding the use of NIV in ALS: results of an international ALS specialist survey.

Heiman-Patterson TD, Cudkowicz ME, De Carvalho M, Genge A, Hardiman O, Jackson CE, Lechtzin N, Mitsumoto H, Silani V, Andrews JA, Chen D, Kulke S, Rudnicki SA, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):331-341. doi: 10.1080/21678421.2018.1457058. Epub 2018 Apr 16.

PMID:
29661084
50.

Author Correction: A replication study of genetic risk loci for ischemic stroke in a Dutch population: a case-control study.

Hauer AJ, Pulit SL, van den Berg LH, de Bakker PIW, Veldink JH, Ruigrok YM; Dutch Parelsnoer Institute-Cerebrovascular accident (CVA) Study Group.

Sci Rep. 2018 Apr 11;8(1):6057. doi: 10.1038/s41598-018-22952-z.

Supplemental Content

Loading ...
Support Center